Sudomotor innervation in transthyretin amyloid neuropathy: Pathology and functional correlates

Annals of Neurology

Volumn 78, Issue 2, 2015, Pages 272-283

  Chao, Chi Chao ^a   Huang, Cho Min ^b   Chiang, Hao Hua ^b   Luo, Kai Ren ^b   Kan, Hung Wei ^b   Yang, Naomi Chu Chiao ^b   Chiang, Hao ^b   Lin, Whei Min ^b   Lai, Shu Mei ^b   Lee, Ming Jen ^a   Shun, Chia Tung ^a,c   Hsieh, Sung Tsang ^a,b,d  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c Department of Forensic Medicine ^*  (Taiwan)

^d Graduate Institute of Brain and Mind Sciences   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BIOLOGICAL MARKER; PREALBUMIN; PROTEIN GENE PRODUCT 9.5; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; UBIQUITIN THIOLESTERASE; UCHL1 PROTEIN, HUMAN;

ADULT; AGED; AMYLOID NEUROPATHY; ARTICLE; ASSESSMENT OF HUMANS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENERVATION; FAMILIAL AMYLOID POLYNEUROPATHY; FEMALE; FOLLOW UP; GENE PRODUCT; HUMAN; IMMUNOHISTOCHEMISTRY; INNERVATION; MALE; NEUROLOGIC DISEASE; NEUROPATHIC PAIN; ORTHOSTATIC HYPOTENSION; PARESTHESIA; PHENOTYPE; PHYSICAL DISABILITY; PRIORITY JOURNAL; SKIN BIOPSY; SUDOMOTOR DEGENERATION; SUDOMOTOR INNERVATION; SWEAT GLAND INNERVATION INDEX; TISSUE DEGENERATION; AUTONOMIC NEUROPATHY; BIOPSY; EPIDERMIS; GENETICS; LEG; METABOLISM; MIDDLE AGED; PATHOLOGY; SKIN; SWEAT GLAND;

AGED; AMYLOID NEUROPATHIES, FAMILIAL; AUTONOMIC NERVOUS SYSTEM DISEASES; BIOLOGICAL MARKERS; BIOPSY; EPIDERMIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEG; MALE; MIDDLE AGED; PREALBUMIN; SKIN; SWEAT GLANDS; UBIQUITIN THIOLESTERASE; VASOACTIVE INTESTINAL PEPTIDE;

EID: 84937727820     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24438     Document Type: Article

References (47)

1. Plante-Bordeneuve V, Said G,. Familial amyloid polyneuropathy. Lancet Neurol 2011; 10: 1086-1097.
2. Ando Y, Nakamura M, Araki S,. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 2005; 62: 1057-1062.
3. Ikeda S, Nakazato M, Ando Y, Sobue G,. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. Neurology 2002; 58: 1001-1007.
4. Yang NC, Lee MJ, Chao CC, et al., Clinical presentations and skin denervation in amyloid neuropathy due to transthyretin Ala97ser. Neurology 2010; 75: 532-538.
5. Freeman R,. Autonomic peripheral neuropathy. Lancet 2005; 365: 1259-1270.
6. Luo KR, Chao CC, Chen YT, et al., Quantitation of sudomotor innervation in skin biopsies of patients with diabetic neuropathy. J Neuropathol Exp Neurol 2011; 70: 930-938.
7. Gibbons CH, Illigens BM, Wang N, Freeman R,. Quantification of sweat gland innervation: a clinical-pathologic correlation. Neurology 2009; 72: 1479-1486.
8. Liu Y, Billiet J, Ebenezer GJ, et al., Factors influencing sweat gland innervation in diabetes. Neurology 2015; 84: 1652-1659.
9. Luo KR, Chao CC, Hsieh PC, et al., Effect of glycemic control on sudomotor denervation in type 2 diabetes. Diabetes Care 2012; 35: 612-616.
10. Vaalasti A, Tainio H, Rechardt L,. Vasoactive intestinal polypeptide (VIP)-like immunoreactivity in the nerves of human axillary sweat glands. J Invest Dermatol 1985; 85: 246-248.
11. Suhr OB, Holmgren G, Steen L, et al., Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients. Transplantation 1995; 60: 933-938.
12. Chao CC, Tsai LK, Chiou YH, et al., Peripheral nerve disease in SARS: report of a case. Neurology 2003; 61: 1820-1821.
13. Chao CC, Hsieh SC, Yang WS, et al., Glycemic control is related to the severity of impaired thermal sensations in type 2 diabetes. Diabetes Metab Res Rev 2007; 23: 612-620.
14. Yarnitsky D, Ochoa JL,. Warm and cold specific somatosensory systems. Psychophysical thresholds, reaction times and peripheral conduction velocities. Brain 1991; 114: 1819-1826.
15. Ravits JM,. AAEM minimonograph #48: Autonomic nervous system testing. Muscle Nerve 1997; 20: 919-937.
16. McCarthy BG, Hsieh ST, Stocks A, et al., Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology 1995; 45: 1848-1855.
17. Chien HF, Tseng TJ, Lin WM, et al., Quantitative pathology of cutaneous nerve terminal degeneration in the human skin. Acta Neuropathol 2001; 102: 455-461.
18. Shun CT, Chang YC, Wu HP, et al., Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. Brain 2004; 127: 1593-1605.
19. Howie AJ, Brewer DB, Howell D, Jones AP,. Physical basis of colors seen in Congo red-stained amyloid in polarized light. Lab Invest 2008; 88: 232-242.
20. Khurana R, Uversky VN, Nielsen L, Fink AL,. Is Congo red an amyloid-specific dye? J Biol Chem 2001; 276: 22715-22721.
21. Prakash R, Bharathi Raja S, Devaraj H, Devaraj SN,. Up-regulation of Muc2 and Il-1beta expression in human colonic epithelial cells by Shigella and its interaction with mucins. PLoS One 2011; 6: e27046.
22. Howie AJ, Brewer DB,. Optical properties of amyloid stained by Congo red: history and mechanisms. Micron 2009; 40: 285-301.
23. Pan CL, Tseng TJ, Lin YH, et al., Cutaneous innervation in Guillain-Barre syndrome: pathology and clinical correlations. Brain 2003; 126: 386-397.
24. Nejsum LN, Praetorius J, Nielsen S,. Nkcc1 and Nhe1 are abundantly expressed in the basolateral plasma membrane of secretory coil cells in rat, mouse, and human sweat glands. Am J Physiol Cell Physiol 2005; 289: C333-C340.
25. Montagna P, Salvi F, Liguori R,. Sympathetic skin response in familial amyloid polyneuropathy. Muscle Nerve 1988; 11: 183-184.
26. Conceicao I, Costa J, Castro J, de Carvalho M,. Neurophysiological techniques to detect early small-fiber dysfunction in transthyretin amyloid polyneuropathy. Muscle Nerve 2014; 49: 181-186.
27. Ando Y, Araki S, Shimoda O, Kano T,. Role of autonomic nerve functions in patients with familial amyloidotic polyneuropathy as analyzed by laser Doppler flowmetry, capsule hydrograph, and cardiographic R-R interval. Muscle Nerve 1992; 15: 507-512.
28. Tanaka M, Hongo M, Kinoshita O, et al., Iodine-123 metaiodobenzylguanidine scintigraphic assessment of myocardial sympathetic innervation in patients with familial amyloid polyneuropathy. J Am Coll Cardiol 1997; 29: 168-174.
29. Coutinho MC, Cortez-Dias N, Cantinho G, et al., Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy. Circ Cardiovasc Imaging 2013; 6: 627-636.
30. Koike H, Misu K, Sugiura M, et al., Pathology of early- vs late-onset Ttr Met30 familial amyloid polyneuropathy. Neurology 2004; 63: 129-138.
31. Wilkinson KD, Lee KM, Deshpande S, et al., The neuron-specific protein Pgp 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science 1989; 246: 670-673.
32. Landis SC, Fredieu JR,. Coexistence of calcitonin gene-related peptide and vasoactive intestinal peptide in cholinergic sympathetic innervation of rat sweat glands. Brain Res 1986; 377: 177-181.
33. Tanaka E, Uchiyama S, Nakano S,. Effects of calcitonin gene-related peptide and vasoactive intestinal peptide on nicotine-induced sweating in man. J Auton Nerv Syst 1990; 30: 265-268.
34. Levy DM, Terenghi G, Gu XH, et al., Immunohistochemical measurements of nerves and neuropeptides in diabetic skin: relationship to tests of neurological function. Diabetologia 1992; 35: 889-897.
35. Verdu E, Vilches JJ, Rodriguez FJ, et al., Physiological and immunohistochemical characterization of cisplatin-induced neuropathy in mice. Muscle Nerve 1999; 22: 329-340.
36. Holzbaur EL, Scherer SS,. Microtubules, axonal transport, and neuropathy. N Engl J Med 2011; 365: 2330-2332.
37. Coelho T, Adams D, Silva A, et al., Safety and efficacy of RNAi therapy for transthyretin amyloidosis. N Engl J Med 2013; 369: 819-829.
38. Coelho T, Maia LF, Martins da Silva A, et al., Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial. Neurology 2012; 79: 785-792.
39. Berk JL, Suhr OB, Obici L, et al., Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial. JAMA 2013; 310: 2658-2667.
40. Provitera V, Nolano M, Caporaso G, et al., Evaluation of sudomotor function in diabetes using the dynamic sweat test. Neurology 2010; 74: 50-56.
41. Gibbons CH, Illigens BM, Centi J, Freeman R,. QDIRT: quantitative direct and indirect test of sudomotor function. Neurology 2008; 70: 2299-2304.
42. Novak V, Freimer ML, Kissel JT, et al., Autonomic impairment in painful neuropathy. Neurology 2001; 56: 861-868.
43. Obayashi K, Ando Y,. Focus on autonomic dysfunction in familial amyloidotic polyneuropathy (FAP). Amyloid 2012; 19 (suppl 1): 28-29.
44. Freeman R,. Clinical practice. neurogenic orthostatic hypotension. N Engl J Med 2008; 358: 615-624.
45. Suzuki T, Higa S, Sakoda S, et al., Orthostatic hypotension in familial amyloid polyneuropathy: treatment with DL-threo-3,4-dihydroxyphenylserine. Neurology 1981; 31: 1323-1326.
46. Delahaye N, Dinanian S, Slama MS, et al., Cardiac sympathetic denervation in familial amyloid polyneuropathy assessed by iodine-123 metaiodobenzylguanidine scintigraphy and heart rate variability. Eur J Nucl Med 1999; 26: 416-424.
47. Said G, Ropert A, Faux N,. Length-dependent degeneration of fibers in Portuguese amyloid polyneuropathy: a clinicopathologic study. Neurology 1984; 34: 1025-1032.